By: Hughes S.B. No. 2796
 
 
 
   
 
  AN ACT
  relating to the Cancer Prevention Research Institute's fiscal
  responsibilities to the state of Texas.
         BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
         SECTION 1.  Section 102.002, Health and Safety Code, is
  amended to read as follows:
         Sec. 102.002.  PURPOSES. The Cancer Prevention and Research
  Institute of Texas is established to:
               (1)  create and expedite innovation in the area of
  cancer research and in enhancing the potential for a medical
  or scientific breakthrough in the prevention of cancer and
  cures for cancer;
               (2)  attract, create, or expand research capabilities
  of public or private institutions of higher education and
  other public or private entities that will promote a
  substantial increase in cancer research and in the creation
  of high-quality new jobs in this state; and
               (3)  develop and implement the Texas Cancer Plan.; and
               (4)  provide a reasonable return on investment for the
  state, with fiduciary responsibilities to the state of Texas,
  with a non-binding target of at least 1% returns per year,
  subject to the decision of the Institute's oversight
  committee.
         SECTION 2.  Section 102.0511(c), Health and Safety Code, is
  amended to read as follows:
               (c)  The chief executive officer shall hire:
                     (1)  one chief scientific officer;
                     (2)  one chief operating officer;
                     (3)  one chief investment officer;
                     (34) one chief product development officer; and
                     (45) one chief prevention officer.
         SECTION 3.  Section 102.251(a-2-C), Health and Safety Code,
  is amended to read as follows:
               (C)  to the extent possible, gives priority to
  proposals that:
                     (i)  could lead to immediate or long-term medical
  and scientific breakthroughs in the area of cancer
  prevention or cures for cancer;
                     (ii)  strengthen and enhance fundamental science
  in cancer research;
                     (iii)  ensure a comprehensive coordinated
  approach to cancer research;
                     (iv)  to the best of the program integration
  committee's knowledge, with consultation by the chief
  investment officer and chief financial officer, is
  expected to be financially viable and to enter the
  market within 15 years of initial investment, provide a
  complete return on initial investment for the state
  within 20 years, as long as a grant is considered by the
  program integration committee to be of extraordinary
  scientific or medical value;
                     (ivv)  are interdisciplinary or
  interinstitutional;
                     (vi)  address federal or other major research
  sponsors' priorities in emerging scientific or
  technology fields in the area of cancer prevention or
  cures for cancer;
                     (vii)  are matched with funds available by a
  private or nonprofit entity and institution or
  institutions of higher education;
                     (viii)  are collaborative between any combination
  of private and nonprofit entities, public or private
  agencies or institutions in this state, and public or
  private institutions outside this state;
                     (viiiix)  have a demonstrable economic
  development benefit to this state;
                     (ix)  enhance research superiority at
  institutions of higher education in this state by
  creating new research superiority, attracting existing
  research superiority from institutions not located in
  this state and other research entities, or enhancing
  existing research superiority by attracting from
  outside this state additional researchers and
  resources;
                     (xi)  expedite innovation and product
  development, attract, create, or expand private sector
  entities that will drive a substantial increase in
  high-quality jobs, and increase higher education
  applied science or technology research capabilities;
  and
                     (xii)  address the goals of the Texas Cancer Plan;
  and
         SECTION 4.  Section 102.255 (c-3), Health and Safety Code,
  is amended to read as follows:
               (3)  specify:
                     (A)  the amount of matching funds to be dedicated
  under Subdivision (2);
                     (B)  the period in which the grant award must be
  spent;
                     (C)  the name of the research project to which
  matching funds are to be dedicated; and
                     (D)  the specific deliverables of the project that
  is the subject of the grant proposal.; and
                     (E)  an agreement by the grant recipient to
  provide bi-annual reports on the anticipated timeline
  for a return on investment for the state's portion of
  the grant money, when taking into consideration the
  progress made by grant recipient and market conditions.
         SECTION 5.  This Act takes effect immediately if it receives
  a vote of two-thirds of all the members elected to each house, as
  provided by Section 39, Article III, Texas Constitution.  If this
  Act does not receive the vote necessary for immediate effect, this
  Act takes effect September 1, 2025.